| Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 171.37 mm | 171.37 mm | 171.37 mm | 171.37 mm | 171.37 mm | 171.37 mm |
| Cash burn (monthly) | 18.48 mm | 3.27 mm | 6.76 mm | 10.18 mm | 21.26 mm | (no burn) |
| Cash used (since last report) | 739.84 mm | 130.98 mm | 270.46 mm | 407.43 mm | 850.97 mm | n/a |
| Cash remaining | -568.46 mm | 40.40 mm | -99.08 mm | -236.06 mm | -679.60 mm | n/a |
| Runway (months of cash) | -30.8 | 12.3 | -14.7 | -23.2 | -32.0 | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 66.93 mm |
| Total shares | 2.79 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Bain Capital Life Sciences Fund | 2.79 mm | $66.93 mm |
